Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
March 25, 2008

Nanobac to Use BioChemics’ Delivery Technology with Prostatitis Compounds

  • Nanobac Pharmaceuticals will utilize BioChemics’ (BCI) drug delivery technology, Vale®, for the transdermal delivery of its prostatitis compounds. Terms of the deal include upfront payments already made, future fees, R&D support, as well as milestones.